Patents by Inventor Mahalakshimi YERRAMILLI

Mahalakshimi YERRAMILLI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Markers for renal disease
    Patent number: 11933792
    Abstract: This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides and fragments thereof provide biomarkers of renal disease and are described herein.
    Type: Grant
    Filed: July 28, 2022
    Date of Patent: March 19, 2024
    Assignee: IDEXX Laboratories, Inc.
    Inventors: Mahalakshimi Yerramilli, Michael Randolph Atkinson, Murthy V. S. N. Yerramilli
  • MARKERS FOR RENAL DISEASE
    Publication number: 20230139188
    Abstract: This invention provides reagents and methods for diagnosing renal disease. Differential levels of inosine metabolite, and proteins: apolipoprotein C-I, apolipoprotein C-II, fibrinogen alpha chain, or fibrinogen A-alpha chain, kininogen, Inter-Alpha Inhibitor H4 (ITIH4), keratin Type I cytoskeletol 10 cystatin A, cystatin B and other polypeptides and fragments thereof provide biomarkers of renal disease and are described herein.
    Type: Application
    Filed: July 28, 2022
    Publication date: May 4, 2023
    Applicant: IDEXX LABORATORIES, INC.
    Inventors: Mahalakshimi YERRAMILLI, Michael Randolph ATKINSON, Murthy V.S.N. YERRAMILLI